Why is India’s obesity drug market thinning despite the GLP-1 rush?
Neetu Chandra Sharma
·
2026-06-10
·
via Business News India: Latest Business News Today, Share Market, Economy
Generic semaglutide launches have expanded access and pushed India's GLP-1 market close to Rs 2,000 crore. Bu…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。